Johnson & Johnson and its subsidiaries have approximately 134,000 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson has more than 260 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. 2017 Sales were $77 billion.
Hughes Hubbard & Reed LLP is an international law firm ranked for 12 years, including five years in a row as the top-ranked New York-based firm, on The American Lawyer’s A-List of what the magazine calls “the top firms among the nation’s legal elite.” We advise and represent clients in over 30 specialized practices. Our firm strikes the balance between scale and agility, handling large and complex matters, while remaining flexible to adapt to clients’ needs and market developments. For more information, please visit www.hugheshubbard.com.
Joseph Campbell is a Director in Navigant’s Global Investigations & Compliance Practice. His role involves leading anti-bribery and corruption, anti-money laundering and financial investigations. Joseph’s experience includes investigation and assessment of cross-border tax matters through review and analysis of business and financial institution international investments and transactions.
Prior to Navigant, Joseph was a Special Agent of the Federal Bureau of Investigation (“FBI”) for more than 25 years. He was the Assistant Director of the Criminal Investigative Division, responsible for a team of 6,000 Special Agents, analysts, and forensic accountants. He developed and led the execution of the FBI global investigative mission and strategies, and criminal intelligence. This included an emphasis in directing white collar crime and public corruption investigations. He integrated cyber security with priority criminal threat mitigation strategies and analysis, directed response to emergency events, and established reliable internal controls and tripwires to ensure compliance with applicable laws, regulations, and guidelines.
Jeff Antoon is an Internal Audit Director at Johnson & Johnson. Jeff leads a group that conducts fraud investigations and proactive Foreign Corrupt Practices Act audits of J&J entities and third party vendors. Jeff has also performed and supervised financial audits at J&J. Jeff has spoken on fraud and FCPA audits at various industry events such as the Center for Business Intelligence, American Conference Institute, Marcus Evans, The Economist, The Knowledge Group, and other industry groups.
Jeff has been with J&J for 31 years. He has a Bachelor of Science in Accounting from Villanova University, a Master of Business Administration from the University of Maryland, and is a Certified Public Accountant.
Kevin is the Deputy Chair of Hughes Hubbard & Reed LLP. He is Co-Chairman of the firm’s Anti-Corruption & Internal Investigations, Securities Litigation and Class Actions practice groups, and a member of the firm’s Executive Committee. Kevin regularly advises clients across myriad industries and geographic regions on the full range of anti-corruption issues. He was appointed as the independent compliance monitor for Innospec by the U.K. Serious Fraud Office, U.S. Department of Justice, and U.S. Securities & Exchange Commission (and with approval from U.S. Office of Foreign Assets Control). Kevin led the engagement for a multinational oilfield services company in its post-DPA activities and served as an independent compliance monitor appointed by the United Nations. Kevin leads the firm’s engagements for several multinational companies subject to investigations and in their post-resolution activities, and has successfully assisted numerous multinational companies in satisfying terms of negotiated settlements with international regulators. Kevin authored a treatise on corporate governance and related issues, Corporate Governance: Avoiding and Responding to Misconduct (Law Journal-Seminars Press 2007) and most recently, Anti-Corruption Law and Compliance: Guide to the FCPA and Beyond (Bloomberg/BNA 2014).